Aravax Company

Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.
Technology: Cancer
Industry: PharmTech
Headquarters: Melbourne, Victoria, Australia
Founded Date: 2015
Employees Number: 11-50
Funding Status: Seed
Investors Number: 2
Last Funding Type: Seed

Visit Website
Register and Claim Ownership